Showing results (191-200 of 566) with videos related to

Sort By:
Pageof 57
ACR Open Rheumatology|January 13, 2025
What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician PerspectivesPhilip J Mease, M Elaine Husni, Evan Siegel, et al.
RMD Open|September 29, 2017
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trialsVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Annals of the Rheumatic Diseases|May 13, 2016
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)Vibeke Strand, Philip Mease, Laure Gossec, et al.
Arthritis Care & Research|November 12, 2015
Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient RegistryVibeke Strand, Jeffrey D Greenberg, Jenny Griffith, et al.
Annals of the Rheumatic Diseases|February 4, 2011
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritisKaren Au, George Reed, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatmentVibeke Strand, Veronika Sharp, Andrew S Koenig, et al.
The Journal of Rheumatology|July 15, 2024
GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic DiseaseArianna J Zhang, Lourdes M Perez-Chada, Vibeke Strand, et al.
Annals of the Rheumatic Diseases|January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisLászló Czirják, Zoltán Nagy, Martin Aringer, et al.
Arthritis Research & Therapy|November 5, 2015
Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDsVibeke Strand, Joel Kremer, Gene Wallenstein, et al.
RMD Open|October 31, 2025
Poor health-related quality of life despite Lupus Low Disease Activity State or Definitions of Remission in systemic lupus erythematosus (SLE) remission in patients with SLE: results from a clinical trial settingIoannis Parodis, Julius Lindblom, Leonardo Palazzo, et al.
Pageof 57